RE:RE:RE:Exciting Developments Unveiled: A Deep Dive into Spectral's If nothing else, it speaks volumes about what our final demand might be once approved. There's been some kerfuffle that our slow enrollment implies that our end demand/penetration will be low, but that couldn't be further from the truth. We currently have a 100+ people per week desperately trying to get PMX. And that's just from 20 hospitals. When you extrapolate that demand to all the hospitals in the USA and you can easily see that PMX will definitely be in high demand. I mean how many hospitals are there in the US, I know it's not just the 20 set up for the Tigris trial right.